1. Home
  2. ANPA vs TTRX Comparison

ANPA vs TTRX Comparison

Compare ANPA & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANPA

Rich Sparkle Holdings Limited Ordinary Shares

HOLD

Current Price

$7.09

Market Cap

103.7M

Sector

N/A

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$4.86

Market Cap

107.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANPA
TTRX
Founded
2016
2015
Country
Hong Kong
United States
Employees
32
2
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.7M
107.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ANPA
TTRX
Price
$7.09
$4.86
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
34.0K
16.5K
Earning Date
02-06-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$2.57
52 Week High
$180.64
$5.98

Technical Indicators

Market Signals
Indicator
ANPA
TTRX
Relative Strength Index (RSI) 45.70 85.13
Support Level $5.39 $4.11
Resistance Level $10.99 $5.12
Average True Range (ATR) 0.93 0.28
MACD 0.28 0.09
Stochastic Oscillator 28.43 92.39

Price Performance

Historical Comparison
ANPA
TTRX

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is a holding company conducting its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (ESG) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through its sole operating subsidiary in Hong Kong. Its segments include Financial printing services such as printing, typesetting and translation, Advisory services including Environmental, Social and Governance Report and Other services.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: